Tags

Type your tag names separated by a space and hit enter

Effectiveness of vitamin E for treatment of long-term tardive dyskinesia.
Am J Psychiatry. 1994 Jun; 151(6):925-6.AJ

Abstract

Eleven patients with tardive dyskinesia were treated in a double-blind study of vitamin E or placebo for 12 weeks. Abnormal Involuntary Movement Scale (AIMS) ratings were performed before and after treatment. Patients receiving vitamin E showed a significant reduction in their AIMS scale score, but patients receiving placebo showed no significant change. Vitamin E had a helpful effect even for patients whose tardive dyskinesia was mild and long-term.

Authors+Show Affiliations

Department of Psychiatry, San Mateo County Mental Health Services, Calif.No affiliation info availableNo affiliation info availableNo affiliation info available

Pub Type(s)

Clinical Trial
Journal Article
Randomized Controlled Trial

Language

eng

PubMed ID

8185007

Citation

Dabiri, L M., et al. "Effectiveness of Vitamin E for Treatment of Long-term Tardive Dyskinesia." The American Journal of Psychiatry, vol. 151, no. 6, 1994, pp. 925-6.
Dabiri LM, Pasta D, Darby JK, et al. Effectiveness of vitamin E for treatment of long-term tardive dyskinesia. Am J Psychiatry. 1994;151(6):925-6.
Dabiri, L. M., Pasta, D., Darby, J. K., & Mosbacher, D. (1994). Effectiveness of vitamin E for treatment of long-term tardive dyskinesia. The American Journal of Psychiatry, 151(6), 925-6.
Dabiri LM, et al. Effectiveness of Vitamin E for Treatment of Long-term Tardive Dyskinesia. Am J Psychiatry. 1994;151(6):925-6. PubMed PMID: 8185007.
* Article titles in AMA citation format should be in sentence-case
TY - JOUR T1 - Effectiveness of vitamin E for treatment of long-term tardive dyskinesia. AU - Dabiri,L M, AU - Pasta,D, AU - Darby,J K, AU - Mosbacher,D, PY - 1994/6/1/pubmed PY - 1994/6/1/medline PY - 1994/6/1/entrez SP - 925 EP - 6 JF - The American journal of psychiatry JO - Am J Psychiatry VL - 151 IS - 6 N2 - Eleven patients with tardive dyskinesia were treated in a double-blind study of vitamin E or placebo for 12 weeks. Abnormal Involuntary Movement Scale (AIMS) ratings were performed before and after treatment. Patients receiving vitamin E showed a significant reduction in their AIMS scale score, but patients receiving placebo showed no significant change. Vitamin E had a helpful effect even for patients whose tardive dyskinesia was mild and long-term. SN - 0002-953X UR - https://www.unboundmedicine.com/medline/citation/8185007/Effectiveness_of_vitamin_E_for_treatment_of_long_term_tardive_dyskinesia_ L2 - https://ajp.psychiatryonline.org/doi/full/10.1176/ajp.151.6.925?url_ver=Z39.88-2003&rfr_id=ori:rid:crossref.org&rfr_dat=cr_pub=pubmed DB - PRIME DP - Unbound Medicine ER -